FoodEurope Issue 4 2016
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
ingredients 29<br />
About DuPont Nutrition &<br />
Health<br />
DuPont Nutrition & Health<br />
combines in-depth knowledge<br />
of food and nutrition with<br />
current research and expert<br />
science to deliver unmatched<br />
value to the food, beverage<br />
and dietary supplement<br />
industries. We are innovative<br />
solvers, drawing on deep<br />
consumer insights and a broad<br />
product portfolio to help our<br />
customers turn challenges into<br />
high-value business<br />
opportunities. More<br />
information is available at<br />
www.food.dupont.com.<br />
placebo-controlled, multicentre<br />
six-month trial demonstrated the<br />
probiotic and synbiotic (fiber plus<br />
probiotic combination) seem to<br />
control body fat mass, especially in<br />
the abdominal area in overweight<br />
adults. The probiotic and synbiotic<br />
treatment groups both<br />
demonstrated reduced energy<br />
intake during the trial and reduced<br />
waist circumference.<br />
“The potential influence of the gut<br />
microbiota on the regulation of<br />
body weight and shape is an<br />
exciting area right now,” said<br />
Megan DeStefano, Probiotics<br />
global marketing lead at DuPont<br />
Nutrition & Health. “Around the<br />
world, consumers are seeking<br />
natural support for weight<br />
management. In DuPont<br />
proprietary market research, we<br />
have identified that 57% of the<br />
global population are confused<br />
about what they should eat and<br />
what will help them achieve weight<br />
goals without making major<br />
lifestyle changes. 1 We believe this<br />
product will give our customers a<br />
great market opportunity.” Of<br />
particular interest, the<br />
improvements in waist<br />
measurements observed in this<br />
study equate to a reduction in one<br />
waist size of pants.<br />
Only the consumption<br />
of the combination of<br />
Bifidobacterium lactis<br />
420 with Litesse ®<br />
Ultra polydextrose<br />
led to improvements in<br />
lean body mass<br />
Methodology<br />
The volunteers in the study were<br />
randomised into one of four groups<br />
and asked to consume the study<br />
product daily for six months.<br />
Subjects consumed either placebo,<br />
microcrystalline cellulose, 12g/d,<br />
the prebiotic fiber Litesse ® Ultra<br />
polydextrose, 12g/d, DuPont<br />
proprietary strain of probiotic<br />
Bifidobacterium lactis 420, 1010<br />
CFU/d in microcrystalline<br />
cellulose, 12g/d, or the<br />
combination of the prebiotic fiber<br />
and the probiotic strain. This study<br />
assessed changes in fat and lean<br />
tissue using a precise tool, dualenergy<br />
X-ray absorptiometry, for<br />
analysis of body composition to<br />
detect changes in different regions<br />
of the body. Both the probiotic and<br />
synbiotic products helped control<br />
body fat mass, leading to an<br />
approximately 1.4kg difference<br />
compared to placebo in those<br />
participants who adhered to the<br />
study protocol. Only the<br />
consumption of the combination of<br />
Bifidobacterium lactis 420 with<br />
Litesse ® Ultra polydextrose led<br />
to improvements in lean body<br />
mass.<br />
“This is the first study to translate<br />
findings from studies of the<br />
probiotic strain Bifidobacterium<br />
lactis 420 done in animal models,<br />
in which it was shown the probiotic<br />
can improve metabolic health in<br />
mice by strengthening gut barrier<br />
function,” said Lotta Stenman,<br />
Ph.D., lead investigator on the<br />
preclinical and clinical trials, with<br />
DuPont Nutrition & Health. “There<br />
is a long history of research on this<br />
particular probiotic strain, starting<br />
from initial findings from cell<br />
culture studies published in 2008.<br />
It is exciting to see the extensive<br />
preclinical and mechanistic work<br />
paved the way for identifying a<br />
benefit to human health.”<br />
The study was conducted following<br />
Good Clinical Practice guidelines<br />
at four research clinics in Finland.<br />
DuPont Nutrition & Health will<br />
continue to conduct research on<br />
the role of probiotic and prebiotic<br />
supplementation on gut microbiota<br />
and outcomes related to obesity<br />
and metabolic syndrome –<br />
conditions that currently affect<br />
over a third of the global<br />
population.<br />
What we do<br />
DuPont has been bringing world-class science and<br />
engineering to the global marketplace in the form of<br />
innovative products, materials, and services since<br />
1802. The company believes that by collaborating with<br />
customers, governments, NGOs and thought leaders<br />
we can help find solutions to such global challenges as<br />
providing enough healthy food for people everywhere,<br />
decreasing dependence on fossil fuels, and protecting<br />
life and the environment.<br />
www.foodmagazine.eu.com issue four | <strong>2016</strong>